DECIPHER LABS LIMITED (DECIPHER.BO)
INR 16.2
(-0.61%)
INR 16.2
(-0.61%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 362.75 Million INR | -20.4% |
| 2022 | 455.72 Million INR | -30.23% |
| 2021 | 653.22 Million INR | 17.57% |
| 2020 | 555.62 Million INR | 131.64% |
| 2019 | 239.86 Million INR | 197.68% |
| 2018 | 80.57 Million INR | 692.86% |
| 2017 | 10.16 Million INR | 170.99% |
| 2016 | 3.75 Million INR | 68.19% |
| 2015 | 2.22 Million INR | 131.5% |
| 2014 | 963.24 Thousand INR | 109.5% |
| 2013 | 459.77 Thousand INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 75.99 Million INR | -29.74% |
| 2023 Q2 | 74.92 Million INR | -21.2% |
| 2023 Q1 | 95.08 Million INR | -2.73% |
| 2023 Q3 | 82.86 Million INR | 10.59% |
| 2023 FY | 358.78 Million INR | -21.27% |
| 2023 Q4 | 105.91 Million INR | 27.82% |
| 2022 Q4 | 97.75 Million INR | -11.59% |
| 2022 Q3 | 110.56 Million INR | -8.8% |
| 2022 Q2 | 121.22 Million INR | -3.94% |
| 2022 FY | 455.72 Million INR | -30.23% |
| 2022 Q1 | 126.19 Million INR | -45.81% |
| 2021 FY | 653.22 Million INR | 17.57% |
| 2021 Q3 | 137.12 Million INR | -8.13% |
| 2021 Q2 | 149.26 Million INR | 11.42% |
| 2021 Q4 | 232.87 Million INR | 69.83% |
| 2021 Q1 | 133.96 Million INR | -4.94% |
| 2020 Q4 | 140.92 Million INR | 2.59% |
| 2020 FY | 555.62 Million INR | 131.64% |
| 2020 Q1 | 142.21 Million INR | -19.16% |
| 2020 Q2 | 135.11 Million INR | -4.99% |
| 2020 Q3 | 137.36 Million INR | 1.67% |
| 2019 Q2 | 12.3 Million INR | -14.73% |
| 2019 Q3 | 37.21 Million INR | 202.44% |
| 2019 FY | 239.86 Million INR | 197.68% |
| 2019 Q1 | 14.42 Million INR | 18.41% |
| 2019 Q4 | 175.91 Million INR | 372.75% |
| 2018 FY | 80.57 Million INR | 692.86% |
| 2018 Q4 | 12.18 Million INR | 90.32% |
| 2018 Q2 | 13.33 Million INR | -72.58% |
| 2018 Q1 | 48.62 Million INR | 1194.28% |
| 2018 Q3 | 6.4 Million INR | -51.97% |
| 2017 FY | 10.16 Million INR | 170.99% |
| 2017 Q4 | 3.75 Million INR | 0.0% |
| 2017 Q3 | 3.75 Million INR | 64.06% |
| 2017 Q2 | 2.29 Million INR | 536.11% |
| 2017 Q1 | 360 Thousand INR | -61.18% |
| 2016 Q2 | 985 Thousand INR | 220.85% |
| 2016 Q3 | 1.53 Million INR | 55.43% |
| 2016 Q4 | 927.34 Thousand INR | -39.43% |
| 2016 FY | 3.75 Million INR | 68.19% |
| 2016 Q1 | 307 Thousand INR | -43.76% |
| 2015 Q4 | 545.87 Thousand INR | -44.92% |
| 2015 Q2 | 447 Thousand INR | 81.71% |
| 2015 FY | 2.22 Million INR | 131.5% |
| 2015 Q1 | 246 Thousand INR | 127.26% |
| 2015 Q3 | 991 Thousand INR | 121.7% |
| 2014 Q3 | 570 Thousand INR | 100.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q2 | 285 Thousand INR | 0.0% |
| 2014 FY | 963.24 Thousand INR | 109.5% |
| 2014 Q4 | 108.24 Thousand INR | -81.01% |
| 2013 FY | 459.77 Thousand INR | 0.0% |
| 2013 Q2 | - INR | 0.0% |
| 2013 Q4 | 459.77 Thousand INR | 0.0% |
| 2013 Q3 | - INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 10.48 Million INR | -3358.237% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | 65.411% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | 9.364% |
| Vasundhara Rasayans Limited | 370.18 Million INR | 2.007% |
| Sunil Healthcare Limited | 901.91 Million INR | 59.78% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -1873.414% |
| MedPlus Health Services Limited | 56.24 Billion INR | 99.355% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | 18.682% |
| Patidar Buildcon Limited | 2.3 Million INR | -15617.201% |
| Roopa Industries Limited | 715.53 Million INR | 49.303% |
| Smruthi Organics Limited | 1.27 Billion INR | 71.581% |
| Trident Lifeline Limited | 446.28 Million INR | 18.717% |
| PANJON LTD. | 125.52 Million INR | -188.998% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -140.041% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | 24.387% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 94.393% |
| Crestchem Limited | 212.56 Million INR | -70.658% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -6433.736% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | 46.084% |
| Tyche Industries Limited | 696.83 Million INR | 47.943% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 89.581% |
| Trimurthi Limited | 42.23 Million INR | -758.831% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | 51.356% |
| Norris Medicines Limited | 56.35 Million INR | -543.68% |
| Zenlabs Ethica Limited | 585.63 Million INR | 38.058% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | 71.075% |
| ANG Lifesciences India Limited | 1.46 Billion INR | 75.173% |
| Parmax Pharma Limited | 154.24 Million INR | -135.182% |
| Veerhealth Care Limited | 142.13 Million INR | -155.219% |
| Deccan Health Care Limited | 597.28 Million INR | 39.267% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 92.174% |
| Makers Laboratories Limited | 1.03 Billion INR | 65.04% |
| Lactose (India) Limited | 1.13 Billion INR | 68.149% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | 8.493% |
| Zenith Healthcare Limited | 144.71 Million INR | -150.664% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | 32.432% |
| Bacil Pharma Limited | - INR | -Infinity% |
| PRAVEG LIMITED | 915.96 Million INR | 60.397% |
| Denis Chem Lab Limited | 1.67 Billion INR | 78.385% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 88.191% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | 74.448% |
| Colinz Laboratories Limited | 70.29 Million INR | -416.036% |
| Godavari Drugs Limited | 1.56 Billion INR | 76.852% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -32346.601% |
| Zenotech Laboratories Limited | 368.08 Million INR | 1.45% |
| Panchsheel Organics Limited | 1.05 Billion INR | 65.524% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | 71.186% |
| Vivanza Biosciences Limited | 278.89 Million INR | -30.069% |
| Phaarmasia Limited | 305.93 Million INR | -18.573% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 97.325% |
| Medi-Caps Limited | 265.63 Million INR | -36.561% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 78.639% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 79.191% |
| Mercury Laboratories Limited | 755.59 Million INR | 51.991% |
| Gennex Laboratories Limited | 867.14 Million INR | 58.167% |
| BDH Industries Limited | 858.31 Million INR | 57.736% |
| Coral Laboratories Limited | 836.6 Million INR | 56.64% |
| Concord Drugs Limited | 449.24 Million INR | 19.253% |
| Bharat Parenterals Limited | 2.59 Billion INR | 86.016% |
| Beryl Drugs Limited | 271.24 Million INR | -33.735% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -252.605% |
| Evoq Remedies Limited | 63.09 Million INR | -474.977% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 82.049% |
| Transchem Limited | 4.09 Million INR | -8747.636% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | -138.848% |
| Parnax Lab Limited | 1.88 Billion INR | 80.777% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | -32.892% |
| Kerala Ayurveda Limited | 1.02 Billion INR | 64.553% |
| Cian Healthcare Limited | 616.95 Million INR | 41.203% |
| Trinity League India Limited | 2.95 Million INR | -12196.712% |
| Syschem (India) Limited | 2.33 Billion INR | 84.467% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 76.66% |
| Auro Laboratories Limited | 526.99 Million INR | 31.166% |